Research To Practice
@DrNeilLove
RTP focuses on an integrated approach to oncology education. Register for weekly CME/NCPD live webinars.
Wednesday, July 23rd, in collaboration with the @CancerCare, Dr Neil Love will explore questions that patients ask about relapsed/refractory multiple myeloma. Register at the link below. ow.ly/TGje50Wj1Fl

During the 2025 Annual ONS Congress, Dr Neil Love hosted a symposium on the role of DLL3-targeting bispecific T-cell engagers for small cell lung cancer. Check out the proceedings: ow.ly/V2Hn50WqtpM


TOMORROW! In partnership with Research To Practice, join us for a special webinar for patients on Wednesday about relapsed/refractory multiple myeloma. @DrNeilLove Register here: researchtopractice.com/Webinars/2025R…
Next week, Dr Neil Love will explore the use of oral selective estrogen receptor degraders for metastatic breast cancer. Register at the link. ow.ly/JPk150Wo1jm

On Wednesday, in collaboration with the @CancerCare, Dr Neil Love will explore questions that patients ask about relapsed/refractory multiple myeloma. Register at the link. ow.ly/6ykV50Wo1eE


Watch or listen to a roundtable discussion on optimizing the selection and sequencing of therapy for patients with relapsed/refractory follicular lymphoma. Link below. ow.ly/lJU250Wo15t

Check out this session from our CME Symposium Series in conjunction with the 2025 ASCO® Annual Meeting about the current and future clinical care of patients with HER2-positive gastrointestinal cancers. ow.ly/Ul8R50Wo111


Couldn't make it to our CME Symposium Series in conjunction with the 2025 ASCO® Annual Meeting? Check out this session where clinical investigators discussed the current and future role of immunotherapy and antibody-drug conjugates in lung cancer. ow.ly/Xf9e50Wo0Sj


Watch or listen to this podcast where esteemed faculty discuss current and future management of immune thrombocytopenia. ow.ly/n8Jk50Wmuhw

A nice virtual discussion with Research to Practice on #SCLC with Drs. @charlesrudin and @DrNeilLove - many advances in small cell lung cancer to discuss including some interesting points brought up by Dr. Estela Rodriguez @Latinamd
Next week, in collaboration with the @CancerCare, Dr Neil Love will explore questions that patients ask about relapsed/refractory multiple myeloma. Register at the link. ow.ly/vsE650Wmuey


In partnership with Research To Practice, join us for a special webinar for patients next Wednesday about relapsed/refractory multiple myeloma. @DrNeilLove Register here: researchtopractice.com/Webinars/2025R…
On Thursday, Dr Neil Love will explore the management of ocular toxicities associated with antibody-drug conjugates and other cancer therapies. Register at the link. ow.ly/MNXf50Wmr8Y

On Wednesday, Dr Neil Love will examine actual cases of patients with small cell lung cancer. Register at the link. ow.ly/haet50Wmr4A

During the 2025 ASCO® Annual Meeting, clinical investigators provided their perspectives on available research guiding the care of patients with non-Hodgkin lymphoma. Link below to watch or listen. ow.ly/77wT50WmqYS


Check out this episode of our podcast where Dr Neil Love interviews Dr Surbhi Sidana about optimizing the role of CAR T-cell therapy in the management of multiple myeloma. ow.ly/ze3W50WmqRL

Appreciate the kind words!
Thank you for the time and effort it must have taken to procure ophthalmologic expertise toward this much needed area of multidisciplinary ocular toxicity management in community settings - excited to follow along as always!
During the 2025 ASCO® Annual Meeting, clinical investigators provided their perspectives on available research guiding the care of patients with colorectal cancer. Link below to watch or listen. ow.ly/VoQ950WmqEo


Next week, Dr Neil Love will explore the management of ocular toxicities associated with antibody-drug conjugates and other cancer therapies. Register at the link in our bio. ow.ly/O08c50WnjlR

Next week, Dr Neil Love will explore actual cases of patients with small cell lung cancer. Register at the link. ow.ly/HciX50Wkyto

Check out the proceedings from a webinar hosted by Dr Neil Love on optimizing the current and future management of relapsed/refractory diffuse large B-cell lymphoma. ow.ly/kBsp50Wkyrb
